IL10 and neoplasm: COX-2 inhibition potentiates macrophage's inflammatory cytokine responses but reduced IL-10 secretion thus might skew overall tumor microenvironment to favor Th1 immune responses which was confirmed by reduced regulatory T cells as well as myeloid derived suppressor cells in etodolac fed mice tumor mass (data not shown).